Lv1
30 积分 2024-11-04 加入
Application of Free Energy Perturbation (FEP) Methodology for Predicting the Binding Affinity of Macrocyclic JAK2 Inhibitor Analogues of Pacritinib
1天前
待确认
Discovering high-affinity type-II inhibitors of JAK2 with a structure-guided bioinformatics approach for cancer treatment
5天前
已完结
New and Practical Synthesis of Momelotinib
8天前
已完结
Labour outcome of women with successful external cephalic version: A prospective study
9天前
已完结
Discovery of 3-(Fluoro-imidazolyl)pyridazine Derivatives as Potent STING Agonists with Antitumor Activity
1个月前
已完结
Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus Kinase 2/Fms-Like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma
1个月前
已完结
Use of ω-Transaminase Enzyme Chemistry in the Synthesis of a JAK2 Kinase Inhibitor
1个月前
已完结
Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease
4个月前
已完结
Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors
5个月前
已完结
RIPK2: a promising target for cancer treatment
5个月前
已完结
皖公网安备34019202002308
